Status: Recruiting
Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)
Hypothesis The use of Abiraterone 250 mg with food + prednisone, without LHRH analogs or blockers (ADT), achieves castration-level testosterone at 30 days in ≥80-90% of cases.
Participants needed: 60
Trial details
Phase: Phase 2Age: 18+Biological sex: MaleType: InterventionalSponsor: SMED Clinical ResearchUpdated: Dec 23, 2025Locations: 3
Eligibility criteria
Age ≥18 years. [+5]
Hypersensitivity to ABI/prednisone; moderate-severe hepatic impairment; uncontro... [+1]